FDA NDC Directory · JSON-LD · Markdown

DANYELZA

NDC 50633-230 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameNaxitamab
Labeler / ManufacturerBTG International Inc.
Marketing categoryBiologic License Application · App BLA761171
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNAXITAMAB (40 mg/10mL)
Marketing started20260901
Package count1

External sources

Source: openFDA. Public-domain (CC0).